For millions of patients, the use of cannabis may be necessary during the COVID-19 pandemic for either acute or chronic medical problems. Although THC and CBD have palliative and immunomodulatory effects, neither have been shown to prevent, treat, or exacerbate COVID-19. However, the administration of cannabinoids during the global COVID-19 pandemic requires caution. While the lack of extensive research prevents the organization from making definitive conclusions, the most current information supports the following:
In light of the increased risks posed by smoking and vaping, Doctors for Cannabis Regulation (DFCR) strongly advises patients to consider oral consumption or topical application of cannabis during the COVID-19 pandemic. These delivery methods are much safer than smoking or vaping at this time. Oral consumption potency, dosage, and onset time may vary widely. We encourage medical cannabis patients to consult with a health professional prior to trying new methods and to “start low and go slow” with oral cannabis products, such as edibles and tinctures. Patients with a consistent cannabinoid regimen who are otherwise healthy are not advised to make extreme changes.According to the Center for Disease Control (CDC), the best way to prevent illness is to avoid being exposed to the virus. To protect yourself from COVID-19 transmission, everyone should:
DFCR serves as the global voice for physicians and other health professionals to advance the legalization and science-based regulation of cannabis. Through education and advocacy efforts, we leverage the influence and expertise of the medical community to realize the legislative changes necessary to promote improved public health, social justice, and consumer protections.